Literature DB >> 26887240

Investigation of Helicobacter pylori antigen in stool samples of patients with upper gastrointestinal complaints.

Zeki Calik1, Murat Karamese2, Osman Acar1, Selina Aksak Karamese3, Yalcin Dicle4, Fatih Albayrak5, Serpil Can6, Bulent Guvendi7, Alpgiray Turgut8, Mustafa Cicek9, Halil Yazgi10.   

Abstract

Helicobacter pylori infection is usually acquired in early childhood and it can persist throughout life without antibiotic treatment. This study aimed to compare the accuracy of the noninvasive H. pylori Stool Antigen Test-applied on the stool samples with the invasive gold standart Rapid Urease Test-applied on the gastric biopy samples of patients with upper gastrointestinal complaints. After endoscopy, biopsy and stool specimens were taken in 122 patients. The infection was detected with rapid urease test which is accepted as gold standart test. Rapid, one-step H. pylori card test was applied to all patients stool specimens. In this study 106 of the 122 patients (86.8%) were positive for H. pylori infection, while 16 of the 122 patients (13.2%) were negative. H. pylori card test was negative in 13 of the 16 patients and was positive in 98 of the 106. The sensitivity, specifity, positive and negative predictive values were 92.45%, 81.25%, 97.02%, and 61.90%, respectively. H. pylori card test is rapid, easy, noninvasive and inexpensive methods for detection H. pylori infection. This test showed high sensitivity and specificity. Additionally, it may be a good alternative to invasive tests for the detection of H. pylori infections especially in children.
Copyright © 2015 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  H. pylori card test; Helicobacter pylori; Rapid urease test; Upper gastrointestinal complaints

Mesh:

Substances:

Year:  2016        PMID: 26887240      PMCID: PMC4822757          DOI: 10.1016/j.bjm.2015.11.022

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


Introduction

Helicobacter pylori (H. pylori) is classified as a gram-negative, spiral-shaped bacterium and a microaerophilic, fastidious, human pathogen. H. pylori infection is usually acquired in early childhood and it can persist throughout life without antibiotic treatment. It affects about 20% of the population in developed countries and more than 90% in the developing world.1, 2, 3, 4 Oral–oral and fecal–oral are the most common methods of transmission. H. pylori specifically colonizes on the gastic mucus layer, and it has developed a variety of mechanisms to survive in the harsh acidic environment of the gastric mucosa. H. pylori contains many virulence factors that cause the infection and contributes to gastric inflammation. It is a major cause of gastric and duodenal ulcer and gastritis, and the organism has been etiologically associated with Mucosal-Associated Lymphoid Tissue (MALT) lymphoma and gastric carcinoma.8, 9 Invasive and non-invasive tests are used in the diagnosis of H. pylori infection. The invasive methods include culture, histology, and urease tests. Biopsy specimens obtained with upper gastrointestinal endoscopy are necessary for these tests.10, 11, 12 The noninvasive methods include stool antigen test (SAT), urea breath test and serology. All the tests have advantages and disadvantages. The rapid urease test (RUT) is a gold standard method for the detection of H. pylori, and it is faster and cheaper than other invasive tests.14, 15 Proton pump inhibitors (PPIs), bismuth-containing compounds and antimicrobial agents may affect the performance of this test by inhibiting urease activity. In addition, other urease-producing microorganisms in the gastric mucosa can cause false positive results.12, 16 SATs are non-invasive and inexpensive methods to detect active H. pylori infection. This test has two versions: enzyme immunoassay and immunochromatography. Eradication of H. pylori infection is evaluated by SATs. Therefore this test is useful before and after H. pylori therapy.2, 16, 17 This study aimed to compare the accuracy of the noninvasive H. pylori Stool Antigen Test (SAT) applied on the stool samples with the invasive gold standart Rapid Urease Test (RUT) applied on the gastric biopy samples of patients with upper gastrointestinal complaints.

Materials and methods

Patient selection and collection of samples

This study was approved by the Local Ethics Committee of Ataturk University, Institute of Health Science with the number of 1466. The subjects were selected from patients with upper gastrointestinal complaints admitted to the Ataturk University, Medical Faculty and Department of Gastroenterology. Of those referred to the endoscopy unit for gastrointestinal endoscopy to evaluate dyspeptic complaints, 122 (49 male, 73 female) were included in this study. Patients taking bismuth preparations, PPIs, H2 receptor antagonists or antibiotics for the last month or taking anti-acids for the last two days were excluded from the study. The first stool samples of all patients were collected immediately after the endoscopy.

Detection of H. pylori in biopsy samples

The RUT (Salubris Helicheck, Boston, USA) was used for the detection of H. pylori on biopsy samples in this study. H. pylori produce an abundance of urease. The urease enzyme hydrolyses urea to release CO2 and NH3. The release of ammonia increases the pH of the medium. The urease activity causes a change in the pH indicator color for positive H. pylori results. All the biopsy specimens were taken from the patients during endoscopy and the RUTs were performed by the clinicians according to the manufacturer's protocol.2, 18

Investigation of H. pylori antigens in stool samples

The rapid, one-step H. pylori card test (H+R H. pylori CARD, Madrid, Spain) was used to investigate the presence of H. pylori antigens in the stool samples. This test is a qualitative immunochromatographic assay for the determination of H. pylori in stool samples. The membrane is precoated with monoclonal antibodies, on the test band region, against H. pylori antigens. During testing, the sample is allowed to react with the colored conjugate (anti-H. pylori monoclonal antibodies-red polystyrene microspheres) predried on the test strip. The mixture then moves up the membrane by capillary action. As the sample flows through the test membrane, the coloured particles migrate. For a positive result, the specific antibodies present on the membrane will capture the colored conjugate. The mixture continues to move across the membrane to the immobilized antibody placed in the control band region, where a red band always appears. The presence of this red band serves as; an internal control for the reagents and verification that sufficient volume was added and proper flow was obtained. The stool samples were evaluated by the card test according to the manufacturer's protocol. A single red band appearing across the central window in the site marked with the control line was considered negative. A red band appearing in the site marked with the result line and in the site marked with the control line was considered positive. A total absence of the control band, regardless of the appearance of the result site was considered invalid.

Statistical analysis

The statistical analysis was performed using SPSS for Windows Version 17.0 (Statistical Package for Social Sciences version 17.0). Positive predictive value, negative predictive value, sensitivity and specificity were evaluated with the following formulas.

Results

The mean age of the 122 patients’ was 45.02 ± 15.134 years. The male patients’ ranged from 18 to 84 years old with a mean age of 44.41 ± 16.075 years. The female patients’ ranged from 18 to 80 years old with a mean age of 45.42 ± 14.568 years. The RUT detected H. pylori in 63 of the 73 female patients (59.4%) and 43 of the 49 male patients (40.6%) with upper gastrointestinal complaints. The RUT-positive patients with upper gastrointestinal complaints had a mean age of 45.21 ± 15.641 years and the RUT-negative patients with upper gastrointestinal complaints had a mean age of 43.75 ± 11.538 years. The relationship between patients with upper gastrointestinal complaints and their ages are shown in Fig. 1. The upper gastrointestinal complaints are most seen in 28–37 and 48–57 age ranges. It means that middle-age patients are under risk of upper gastrointestinal diseases.
Fig. 1

The age groups of patients with upper gastrointestinal complainments.

Of the subjects, 106 (86.8%) were diagnosed with gastritis and 16 (13.2%) were diagnosed with ulcer by endoscopic biopsy. For the 106 RUT-positive patients, 91 (85.8%) were diagnosed with gastritis and 15 (14.2%) were diagnosed with ulcer. For the gastritis patients diagnosed by endoscopy, 91 (85.8%) were H. pylori positive according to the RUT. The RUT also tested positive for 15 (93.75%) of the patients with ulcers diagnosed by endoscopy (Table 1).
Table 1

Comparison of endoscopic findings and rapid urease test results.

DiagnosisRapid urease test positiveRapid urease test negativeTotal
Gastritis9115106
Ulcer15116
Total10616122
H. pylori infection was positive in 106 patients according to the RUT. Among these patients, 98 (93.75%) were positive for H. pylori according to the immunochromatographic assay (rapid one-step H. pylori card test). In addition, 3 (18.75%) of the RUT-negative patients were positive according to this method (false positive). In regards to the endoscopy diagnosis, 85 of the 91 (93.4%) H. pylori-positive gastritis patients and 13 of the 15 (86.6%) H. pylori-positive ulcer patients were positive according to the immunochromatographic assay. In addition, 12 of the 15 (80%) H. pylori-negative gastritis patients and the single H. pylori-negative ulcer patients were negative according to the card test (Table 2).
Table 2

All the data about the test results and diagnosis of patients.

DiagnosisRapid urease test resultsH. pylori Card Test PositiveH. pylori Card Test NegativeTotal
GastritisPositive85691
Negative31215
UlcerPositive13215
Negative011
Total10121122
The H. pylori card test and RUT results were compared and positive predictive value, negative predictive value, sensitivity and specificity were evaluated for the card test (Table 3).
Table 3

Evaluation of H. pylori card test with rapid urease test.

H. pylori Card TestRapid urease test
PositiveNegativeTotal
Positive983101
Negative81321
Total10616122

Sensitivity; 98/(98+8) × 100 = 92.45%

Specificity; 13/(3+13) × 100 = 81.25%

Positive predictive value; 98/(98+3) × 100 = 97.02%

Negative predictive value; 13/(8+13) × 100 = 61.90%

False positive rate; 1 − 0.812 = 0.188 = 18.8%

False negative rate; 1 − 0.924 = 0.076 = 7%.

Discussion

Approximately half of the world's population is infected with H. pylori. H. pylori infection is especially a public-health problem in developing countries. It is the leading cause of various upper gastroduodenal tract diseases such as gastric and duodenal ulcer, gastritis, MALT and gastric carcinoma.9, 13, 15 H. pylori infection can be detected by invasive and noninvasive methods. Endoscopy is necessary for the invasive tests. All these methods have advantages and disadvantages.14, 16 The RUT is an invasive method and considered a gold standard. This test is inexpensive and allows for the rapid detection of H. pylori. The test may result in false negative if the patient recently used antimicrobial agents, PPIs or bismuth-containing compounds or a heterogeneous distribution of bacteria is present in the gastric mucus layer. In addition, contamination of the biopsy with saliva or other urease producing microorganisms in the gastric mucosa can cause false positive results. This test's sensitivity, specificity, and positive predictive values are more than >98%, 99%, and 99%, respectively.12, 15, 19 The RUT was used as the gold standard method and compared with the immunochromatographic assay (H. pylori card test) in this study. The study examined 122 patients with upper gastrointestinal complaints especially ulcer and gastritis. The patients’ biopsy specimens and stool samples were examined with the RUT and one-step H. pylori card test, respectively. Of these patients, 106 (86.8%) were positive for H. pylori infection; while 16 (13.2%) were negative. The sensitivity, specificity, positive predictive value and negative predictive value of the H. pylori card test were 92.45%, 81.25%, 97.02%, and 61.90%, respectively. In current literature, the sensitivity and specifity of the card test were 87.8%, 93.8% and 75–100%, respectively.11, 20, 21, 22, 23, 24, 25 These results are similar to our study and showed that performance of the card test was excellent for the noninvasive detection of H. pylori. In addition, previous studies have shown that the H. pylori card test exhibits good performance before and after eradication therapy.22, 26 In our study, 3 of the 16 (18.75%) RUT-negative patients were found positive according to the H. pylori card test (false positive). A cross-reaction with an antigen from Helicobacter species or other microorganism of the intestinal flora may cause false positive results.27, 28 On the other hand, the irregular distribution of bacteria in the gastric mucosa can cause suspect false negative results with the RUT. Among the 106 RUT-positive patients, 8 (7.25%) were considered as negative (false negative) according to the immunochromatographic assay of the stool samples. Card test characteristics or the application of the test may have caused false negative results. Additionally, contamination of the biopsy with saliva or other urease producing microorganisms in the gastric mucus layer can cause false positive results with the RUT.12, 19 Infections caused by H. pylori usually affect adults. In many previous studies, patient's age ranged from 23 to 89 years.20, 29, 30 In the current study, patient's age ranged from 18 to 84 years. No children were included; however, previous studies have shown that the rapid one-step immunochromatographic card test performs well for the detection of H. pylori infection in children's stool samples.26, 30

Conclusions

In conclusion, the H. pylori card test is rapid, easy, noninvasive and inexpensive method for the detection of H. pylori infection. This test showed high sensitivity and specificity. No significant difference was found in sensitivity or specificity between the RUT (the gold standard method) and the one-step H. pylori card test. On the other hand, H. pylori in the stool is not a diagnosis of ulcer and/or gastritis. So, invasive examination should also be done to confirm the diagnosis. However, this test can be used in some insufficient conditions such as if endoscopy is not available. Additionally, the H. pylori card test has exhibited good performance before and after eradication therapy and it is a good alternative to invasive tests for the detection of H. pylori infection in children.

Conflicts of interest

The authors declare no conflicts of interest.
  28 in total

1.  Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study.

Authors:  L Trevisani; S Sartori; M R Rossi; M Ruina; V Matarese; S Gullini; V Abbasciano
Journal:  Aliment Pharmacol Ther       Date:  2005-02-15       Impact factor: 8.171

2.  Evaluation of a rapid new stool antigen test for diagnosis of Helicobacter pylori infection in adult patients.

Authors:  Rea Krausse; G Müller; M Doniec
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

3.  Evaluation of a novel rapid one-step immunochromatographic assay for detection of monoclonal Helicobacter pylori antigen in stool samples from children.

Authors:  David Antos; Julia Crone; Nikolaos Konstantopoulos; Sibylle Koletzko
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 4.  Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors:  Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Validation of a rapid stool antigen test for diagnosis of Helicobacter pylori infection.

Authors:  Joyce Matie Kinoshita da Silva; Cibele Aparecida Villares; Maria do Socorro Monteiro; Carlos Colaúto; Anibal Ferreira dos Santos; Rejane Mattar
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2010 May-Jun       Impact factor: 1.846

6.  A rapid immunochromatographic assay for Helicobacter pylori in stool before and after treatment.

Authors:  L Gatta; F Perna; C Ricci; J F Osborn; A Tampieri; V Bernabucci; M Miglioli; D Vaira
Journal:  Aliment Pharmacol Ther       Date:  2004-08-15       Impact factor: 8.171

Review 7.  Ghrelin and Helicobacter pylori infection.

Authors:  Hiroyuki Osawa
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

Review 8.  Antimicrobial activity of natural products against Helicobacter pylori: a review.

Authors:  Bruna Vidal Bonifácio; Matheus Aparecido dos Santos Ramos; Patricia Bento da Silva; Taís Maria Bauab
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-11-19       Impact factor: 3.944

9.  Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients.

Authors:  Ivy Bastos Ramis; Ernani Pinho de Moraes; Márcia Silveira Fernandes; Raul Mendoza-Sassi; Obirajara Rodrigues; Carlos Renan Varela Juliano; Carlos James Scaini; Pedro Eduardo Almeida da Silva
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

Review 10.  H. pylori virulence factors: influence on immune system and pathology.

Authors:  Behnam Kalali; Raquel Mejías-Luque; Anahita Javaheri; Markus Gerhard
Journal:  Mediators Inflamm       Date:  2014-01-21       Impact factor: 4.711

View more
  4 in total

1.  Hyperemesis Gravidarum in First-Trimester Pregnant Saudi Women: Is Helicobacter pylori a Risk Factor?

Authors:  Khulood S Hussein
Journal:  Front Physiol       Date:  2020-06-24       Impact factor: 4.566

2.  The Evaluation of Diagnostic and Predictive Values of Helicobacter pylori Stool Antigen Test in Iranian Patients with Dyspepsia.

Authors:  Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Zahedin Kheyri; Davood Azizi; Farzin Roozafzai; Samaneh Khorrami
Journal:  Iran J Pathol       Date:  2018

3.  Feco-prevalence and risk factors of Helicobacter pylori infection among symptomatic patients at Dessie Referral Hospital, Ethiopia.

Authors:  Abdurahaman Seid; Wondmagegn Demsiss
Journal:  BMC Infect Dis       Date:  2018-06-07       Impact factor: 3.090

4.  Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru.

Authors:  Miguel Angel Aguilar-Luis; Fernando Palacios-Cuervo; Fátima Espinal-Reyes; Andrea Calderón-Rivera; Saúl Levy-Blitchtein; Carlos Palomares-Reyes; Wilmer Silva-Caso; Victor Zavaleta-Gavidia; Jorge Bazán-Mayra; Angela Cornejo-Tapia; Juana Del Valle-Mendoza; Luis J Del Valle
Journal:  BMC Res Notes       Date:  2018-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.